Associate Professor of Medicine (Nephrology) and Public Health (Chronic Disease Epidemiology); Director, Clinical and Translational Research Accelerator (CTRA); Course Director, Interpretation of the Medical Literature; Co Director, Human Genetics and Clinical Research Core
Drug Targeted Alerts for Acute Kidney Injury Amelioration (ELAIA-2)
This trial will randomize patients with acute kidney injury (AKI) who are receiving a kidney-toxic medication to alerts (highlighting the particular medication) versus usual care.
Leadership
Collaborators
Aditya Biswas
Research Assistant, Yale University
Amit Garg, MD, PhD
Professor of Medicine (Nephrology), Western University, London, Ontario, Canada
Stephen Latham, JD, PhD
Director, Interdisciplinary Center for Bioethics, Yale University
Melissa Martin
Research Associate, Yale University
Paul M. Palevsky, MD
Professor of Medicine, Renal-Electrolyte Division, University of Pittsburgh
Chirag R. Parikh, MD, PhD
Adjunct Professor of Medicine, Yale University
Yu Yamamoto
Statistician, Yale University